James Meyers

James Meyers

Director/Board Member presso ARBUTUS BIOPHARMA CORPORATION

Patrimonio netto: 33 232 $ in data 31/03/2024

58 anni
Health Technology
Commercial Services
Consumer Services

Profilo

James R.
Meyers
is currently the President & Chief Executive Officer at IntraBio, Inc. He is also an Independent Director at Sangamo Therapeutics, Inc., a Director at the Biotechnology Innovation Organization, an Independent Director at Arbutus Biopharma Corp., a Director at Pulmocide Ltd., an Independent Director at CytomX Therapeutics, Inc., and a Director at the California Biomedical Innovation Alliance.
Previously, he worked at Gilead Sciences, Inc. as the Executive VP-Worldwide Commercial Operations from 2016 to 2018.
Mr. Meyers completed his undergraduate degree at Boston College.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
01/06/2023 49 600 ( 0.02% ) 33 232 $ 31/03/2024
19/03/2024 0 ( -.--% ) - $ 31/03/2024
24/05/2023 0 ( -.--% ) - $ 31/03/2024

Posizioni attive di James Meyers

SocietàPosizioneInizio
ARBUTUS BIOPHARMA CORPORATION Director/Board Member 23/10/2018
CYTOMX THERAPEUTICS, INC. Director/Board Member 20/12/2018
SANGAMO THERAPEUTICS, INC. Director/Board Member 22/11/2019
Director/Board Member -
Director/Board Member -
Chief Executive Officer 24/11/2020
Director/Board Member -
Tutte le posizioni attive di James Meyers

Precedenti posizioni note di James Meyers

SocietàPosizioneFine
GILEAD SCIENCES, INC. Corporate Officer/Principal 22/02/2018
Vedi nel dettaglio l'esperienza di James Meyers

Formazione di James Meyers

Boston College Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di James Meyers

Relazioni

100 +

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa4
GILEAD SCIENCES, INC.

Health Technology

SANGAMO THERAPEUTICS, INC.

Health Technology

ARBUTUS BIOPHARMA CORPORATION

Health Technology

CYTOMX THERAPEUTICS, INC.

Health Technology

Aziende private4

Commercial Services

Health Technology

Health Technology

Health Technology

Vedi le connessioni aziendali